Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 1,920† | 1,741† | 1,522† | 1,348† | 1,245† |
| Net profit | 244 | 77 | 300 | 398 | 417† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| AMIT INDUBHUSHAN BAKSHI | Executive Director | June 30, 2026 |
| INDERJEET SINGH NEGI | Executive Director | June 30, 2026 |
| KAUSHAL KAMLESH SHAH | Executive Director | June 30, 2026 |
| KRISHNAKUMAR VAIDYANATHAN | Executive Director | June 30, 2026 |
| KALPANA VASANTRAI UNADKAT | Independent Director | June 30, 2026 |
| PRASHANT GUPTA | Independent Director | June 30, 2026 |
| SUJESH VASUDEVAN | Independent Director | June 30, 2026 |
| VINEET VARMA | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
